Azacitidine Injection, Powder, Lyophilized, For Solution
Product Images NDC 31722-365

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Azacitidine (NDC 31722-365). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Azacitidinefigure (Azacitidinefigure)

The data provided shows the results of a statistical analysis using the Log-Rank test, with a p-value of 0.0001 indicating statistical significance. The analysis includes hazard ratios (HR) and confidence intervals for two groups (Aza and CCR) along with the number of deaths in each group. Additionally, a survival curve is displayed, showing the number of individuals at risk over time (in months) for both groups. This information is likely related to a comparison of outcomes between the two groups in a clinical study or trial.*

FDA Label Image

Azacitidineinjectioncarton (Azacitidineinjectioncarton)

Batch coding details will be coded online including GTIN, serial number, expiration date, and batch number. This information will be part of a 2D Data Matrix for easy tracking and identification. The provided medication is an azacitidine injection meant for subcutaneous and intravenous use only. It comes in a single-dose vial and should be stored at specific temperatures. The product is manufactured by Camber Pharmaceuticals, Inc. and Hetero Labs Limited in India.*

FDA Label Image

Azacitidineinjectionvial (Azacitidineinjectionvial)

This is information about a medication called "Azacitidine" for injection in a 100 mg/vial dosage form. It is intended for subcutaneous and intravenous use only. The single-dose vial contains 100 mg of Azacitidine and 100 mg of Mannitol. It is advised to refer to the prescribing information for dosage and administration guidelines. Any unused portion of the single-dose vial should be discarded. The medication should be stored at 25°C with excursions permitted between 15° to 30°C. Manufacturer contact information is also provided for further queries.*

FDA Label Image

Azacitidinestructure (Azacitidinestructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.